Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day
-
AdaptHealth Corp. Announces Third Quarter 2026 Results
-
2026 Tropical Rainforest Ecosystem Partners Conference: Global Gathering to Protect Earth's Green Lungs
-
GBA Science Forum 2026 Held Across Guangdong, Hong Kong, and Macao: Driving Collaborative Innovation to Build a Global Sci-Tech Hub
-
Animal Outpatient Specialty Network Acquires a Portfolio of Outpatient Specialty Practices
-
Vital Farms Reports Third Quarter 2026 Financial Results
-
Yum! Brands Reports Third-Quarter Results
-
Main Street Announces First Quarter 2027 Regular Monthly Dividends, Including a Monthly Dividend Increase, and Supplemental Dividend Payable in December 2026
-
Bowhead Specialty Holdings Inc. Reports Third Quarter 2026 Results
-
Similarweb to Announce Third Quarter 2026 Financial Results on November 17, 2026, Before Market Open
-
Medicare Expands Coverage for Signatera™ MRD Test in Hepatocellular Carcinoma
-
Entegris Enters Silicon Carbide and Diamond-Enabled Thermal Management Materials Market for AI Advanced Packaging
-
Bridge to Life™ Expands North American Commercial Footprint with Regulatory Milestones in the U.S. and Canada
-
Omnicom Media Again Named Best Performing Global Media Group, Earns #1 Ranking Across All Four Regions
-
Banking Leader Casey Christopher Joins KlariVis to Help Community Banks Navigate the Future of Data and AI
-
Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders
-
Broadridge Reports First Quarter Fiscal 2027 Results
-
Glaukos Announces Participation in Upcoming Investor Conferences
-
Parabilis Medicines to Participate in Upcoming November Investor Conferences
-
BlackSky to Host Investor Day on December 2, 2026
-
Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London
-
Driven Brands Announces Financial Restatement; Provides Update on Third Quarter 2026 Performance and Revises Fiscal Year 2026 Outlook
-
Micro-Epsilon to Integrate Aeva’s Eve High-Precision Technology in Next-Generation Sensing Solutions for Factory Automation
-
ProMat—The Biggest Supply Chain Event of 2027 Returns to Chicago April 19-21
-
OSSTEC Closes $8 Million to Fund First-in-Human & U.S. Launch of ASCENT Cementless Partial Knee and Advance Pipeline
-
Luckin Coffee Announces Third Quarter 2026 Financial Results
-
Aurora Mobile's EngageLab Partners with SKYWORTH Solar to Support Global Channel Operations and Project Delivery with AppPush
-
Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%
-
The Ramage Law Group Opens North Dallas Family Law Office Near the Dallas–Collin County Line
-
LGI Homes, Inc. Reports Third Quarter 2026 Results
-
NextEra Energy and Dominion Energy strengthen historic Virginia benefits package with additional customer and financial safeguards
-
Envoy Technologies Expands into Southwest Florida with EV Car Sharing at $100 Million Midtown Redevelopment
-
ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November
-
Talen Energy Reports Third Quarter 2026 Results, Reaffirms 2026 Guidance, and Introduces 2027 Guidance
-
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
-
Strata Critical Medical Announces Third Quarter 2026 Results
-
Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update
-
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
-
C4 Therapeutics to Participate in Upcoming November Investor Conferences
-
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
-
Sportradar Reports Third Quarter 2026 Financial Results
-
Blue Point-Backed RSI Bolsters Midwest Building Restoration Platform with Wells Masonry Acquisition
-
Beam Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Clinical Progress Across Base Editing Portfolio
-
Fiserv Reports Third Quarter 2026 Results
-
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
KBW Appoints Mark Tweedie as Head of European Investment Banking


